Stock comparison
Madrigal Pharmaceuticals
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDGL
Madrigal Pharmaceuticals
Market cap
$11.93B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDGL | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 26F | 69B | MTD |
| Benjamin Graham | 60D | 65B | MTD |
| Philip Fisher |
Side-by-side metrics
| Metric | MDGL | MTD |
|---|---|---|
| Market cap | $11.93B | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | - | 21.6x |
| ROIC (TTM) | -35.2% | 36.09% |
| Gross margin | 93.07% | 57.79% |
| Net margin | -27.32% | 21.4% |
| Revenue CAGR 5y | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDGL leads on
- EV/EBIT-vs 21.6x+153%
- P/E (TTM)-vs 25.3x+151%
- Gross margin93.07%vs 57.79%+38%
MTD leads on
More like MTD
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.